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Serratia marcescens is a Gram-negative nosocomial pathogen often causing hospital-acquired urinary tract, bloodstream, and other infections ([@B1]). Treating S. marcescens infections can prove difficult due to its panresistance, including that to metallo-beta-lactamases ([@B2]). Due to this wide range of antibiotic resistance, bacteriophage therapy may be a more effective treatment. To that end, the novel myophage Moabite was isolated, and we present its genome sequence here.

Moabite was isolated from a combination of filtered (0.22 μm) and chloroform-sterilized U.S. swine farm samples based on its ability to grow on S. marcescens D1 (catalog no. 8887172; Ward's Science). Both the host and phage were cultured as described by Adams at 30°C in LB broth and agar (BD), and phage were propagated by the soft-agar overlay method ([@B3]). The morphology of Moabite was determined by samples negatively stained with 2% (wt/vol) uranyl acetate and imaged by transmission electron microscopy at the Texas A&M University Microscopy and Imaging Center ([@B4]). The genomic DNA for Moabite was purified with the Promega Wizard DNA clean-up kit according to the modification in the shotgun library preparation protocol given by Summer ([@B5]), and then genomic libraries were generated with an Illumina TruSeq nano low-throughput kit. Prepared genomic DNA was sequenced using an Illumina MiSeq platform with 250-bp paired-end reads. We used FastQC (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>) to quality control the 413,089 total reads in the phage-containing index. These reads were trimmed by the FASTX-Toolkit v0.0.14 (<http://hannonlab.cshl.edu/fastx_toolkit/>). Assembly into a single contig at 287-fold coverage was accomplished with SPAdes v3.5.0, with default parameters ([@B6]). The contig was confirmed to be complete by PCR (forward, 5′-CCTGCGTATGTATTCCTGGATAA-3′; reverse, 5′-TTCTTGGTGACATCGTGGTC-3′ primers) and Sanger sequencing. Gene prediction was achieved using GLIMMER v3.0 and MetaGeneAnnotator v1.0 ([@B7], [@B8]). tRNA genes were found with ARAGORN v2.36 ([@B9]). The presence of rho-independent terminators was predicted with TransTermHP v2.09 ([@B10]). Gene functions were predicted using InterProScan v5.22-61, TMHMM v2.0, and BLAST v2.2.31, with a minimum expectation cutoff of 0.001 against the NCBI nonredundant, UniProtKB Swiss-Prot, and TrEMBL databases ([@B11][@B12][@B14]). HHpred with ummiclust30_2018_08 for multiple-sequence alignment (MSA) generation and PDB_mmCIF70 for modeling in the HHsuite v3.0 release provided supplementary evidence for functional prediction ([@B15]). Whole-genome sequence identities were calculated with progressiveMauve v.2.4.0 ([@B16]). These annotation tools are available on the Center for Phage Technology Galaxy and Web Apollo instances (<https://cpt.tamu.edu/galaxy-pub>) ([@B17], [@B18]).

Moabite is a myophage with a 273,933-bp genome, 340 predicted protein-coding genes, a G+C content of 46.8%, and a coding density of 94.1%. Functions were predicted for 111 coding regions. The G+C content on Moabite is lower than that of its host, S. marcescens, which has G+C contents ranging from 50.9% to 59.6%, depending on the strain ([@B19]). PhageTerm predicts that Moabite uses a headful packaging mechanism, and the genome was reopened in front of the terminase genes ([@B20]). From the BLASTp analysis, Moabite shares 312 proteins with *Serratia* phage 2050HW (GenBank accession no. [MF285618](https://www.ncbi.nlm.nih.gov/nuccore/MF285618)), and progressiveMauve shows overall 93.57% nucleotide identity with the same phage ([@B21]). Unlike for 2050HW, the i-spanin/o-spanin (NCBI accession no. [QDB71172](https://www.ncbi.nlm.nih.gov/protein/1682780995) and [QDB71173](https://www.ncbi.nlm.nih.gov/protein/1682780996), respectively) and endolysin (NCBI accession no. [QDB71048](https://www.ncbi.nlm.nih.gov/protein/1682780871)) genes were predicted for Moabite, but no holin gene was positively identified based on sequence similarity.

Data availability. {#s1.1}
------------------

The genome sequence and associated data for phage Moabite were deposited under GenBank accession no. [MK994515](https://www.ncbi.nlm.nih.gov/nuccore/MK994515), BioProject accession no. [PRJNA222858](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA222858), SRA accession no. [SRR8869230](https://trace.ncbi.nlm.nih.gov/Traces/sra/?run=SRR8869230), and BioSample accession no. [SAMN11360396](https://www.ncbi.nlm.nih.gov/biosample/SAMN11360396).

This work was supported by funding from the National Science Foundation (awards EF-0949351 and DBI-1565146). Additional support came from the Center for Phage Technology (CPT), an Initial University Multidisciplinary Research Initiative supported by Texas A&M University and Texas AgriLife, and from the Department of Biochemistry and Biophysics at Texas A&M University.

We are grateful for the advice and support of the CPT staff.

This announcement was prepared in partial fulfillment of the requirements for BICH464 Bacteriophage Genomics, an undergraduate course at Texas A&M University.

[^1]: **Citation** Price L, Rohren M, Newkirk H, Liu M, Ramsey J. 2019. Complete genome sequence of *Serratia marcescens* myophage Moabite. Microbiol Resour Announc 8:e00741-19. <https://doi.org/10.1128/MRA.00741-19>.
